Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lencura Direct is a healthcare company specializing in advanced wound care management and the distribution of regenerative medical products. The company offers a diverse portfolio of therapies, including amniotic tissue allografts, skin substitutes, and specialized dressings designed to treat chronic and non-healing wounds. Lencura Direct distinguishes itself by providing comprehensive clinical support and streamlining the insurance and logistics process for healthcare providers and patients. By focusing on evidence-based solutions, the company aims to improve patient outcomes in the treatment of diabetic foot ulcers, venous leg ulcers, and pressure sores.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LENCURA Direct.